Canadian Biotechnology Innovation and Commercialization (CBIC)
Biotechnology leverages biological processes, organisms, or systems to develop products and technologies for a wide range of sectors, including medicine, agriculture, and environmental science, with the potential to address global challenges and enhance quality of life. The field has been significantly revolutionized by genomics, which provides a deeper understanding of the genetic basis of life. This has enabled precise manipulation and understanding of biological systems at a molecular level, driving innovation across multiple sectors.
Genome Canada has announced a strategic investment in commercialization and adoption of genomics and genomics-driven biotechnology solutions, through the Canadian Biotechnology Innovation and Commercialization (CBIC) initiative. CBIC funds public-private research and development projects that amplify the value of public investment in innovation and accelerate the commercialization of Canadian genomics inventions and innovations by addressing real-world needs and opportunities identified by industry.
This first investment in support of the Canadian Genomics Strategy aims to accelerate commercialization and adoption to address urgent health and industry challenges in Canada.